Brookline, MA, United States of America

Kenneth S Koblan

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • Brookline, MA (US) (2018)
  • Sudbury, MA (US) (2019 - 2022)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Kenneth S. Koblan

Introduction

Kenneth S. Koblan is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compositions for medical treatments. With a total of 8 patents to his name, Koblan's work has had a meaningful impact on the treatment of various diseases and disorders.

Latest Patents

One of Koblan's latest patents focuses on nonracemic mixtures and their uses. This patent provides compositions that comprise unequal mixtures of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof. The amount of (R)-amisulpride is greater than that of (S)-amisulpride. These compositions and medicaments are used for the treatment of various diseases and disorders, along with methods for their application, including dosage regimens. Additionally, the patent outlines various formulations, including those employing polymorphs of enantiomeric amisulpride.

Career Highlights

Koblan is currently associated with Sunovion Pharmaceuticals Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients.

Collaborations

Some of his notable coworkers include Seth C. Hopkins and John R. Snoonian. Their collaborative efforts contribute to the ongoing research and development initiatives at Sunovion Pharmaceuticals Inc.

Conclusion

Kenneth S. Koblan's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the industry and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…